Marijuana Use Rises as Alcohol Consumption Falls Across U.S.

The Substitution Question

Cannabis use among U.S. adults reached 22% in 2026, up from 19% in 2024, while past-month alcohol consumption fell to 58%, down from 63% two years prior. The inverse trajectories have reignited discussion among public-health researchers and beverage-industry analysts about whether legalization is driving a direct substitution effect.

The data comes from the National Survey on Drug Use and Health, which tracks self-reported consumption patterns across all 50 states. States with adult-use markets showed steeper alcohol declines than prohibition states, though causality remains contested.

Dispensary Operators See the Shift Firsthand

Budtenders and dispensary owners report a growing cohort of customers who frame cannabis as a healthier alternative to nightly drinking. Maria Gonzalez manages a dispensary in Denver. Her evening rush now includes a steady stream of professionals in their 30s and 40s who explicitly describe swapping wine for edibles.

"They'll say, 'I used to have two glasses of wine after work, now I take a 5mg gummy,'" Gonzalez said. "It's not just younger customers anymore. Parents. Executives. People who never touched cannabis until it was legal."

Beverage Industry Responds with Cannabis Drinks

Major alcohol companies have poured hundreds of millions into cannabis-infused beverage startups since 2023, hedging against the decline in beer and spirits sales. Constellation Brands, Molson Coors, and Anheuser-Busch InBev all operate cannabis-drink subsidiaries targeting the same shelf space as hard seltzers.

Sales of THC beverages grew 41% year-over-year in 2026, according to market-research firm Headset, making it the fastest-growing cannabis category. The drinks are marketed explicitly as "session" products—low-dose, social, and positioned as beer replacements.

Public Health Experts Debate the Trade-Off

Epidemiologists remain split on whether the substitution represents a net public-health gain or introduces new risks. Alcohol is linked to roughly 95,000 U.S. deaths annually. No fatal cannabis overdoses have been recorded. But long-term cannabis use carries cognitive and respiratory risks that aren't yet fully quantified at population scale.

Dr. Kevin Sabet, president of Smart Approaches to Marijuana, cautioned against framing the trend as unambiguously positive. "We're not trading one harmless substance for another," he said. "We're trading known harms for unknown harms in a commercial market that's largely unregulated."

Younger Cohorts Drive the Trend

Adults aged 21-34 showed the steepest divergence, with cannabis use at 34% and alcohol at 52%, a near-inversion from 2019 patterns. That demographic also reports the highest rates of dual use, complicating the substitution narrative. Roughly 18% of young adults now use both substances regularly, up from 12% in 2021.

The data suggests partial rather than total substitution for most users. Cannabis appears to be claiming occasions—particularly weeknight relaxation—that once belonged exclusively to alcohol.

State-Level Patterns Reinforce the Link

The ten states with the longest-running adult-use programs saw alcohol sales decline an average of 9% between 2021 and 2026, compared to 3% in prohibition states. Colorado, Oregon, and Washington led the pack, with beer sales down double digits over the five-year span.

Liquor-store owners in legal markets report the trend anecdotally. "Friday and Saturday are still strong, but Monday through Thursday is softer every year," said Tom Brennan, who owns three liquor stores in Portland. "People are finding other ways to unwind."

What Comes Next

The next major data point arrives in early 2027, when the CDC releases its Behavioral Risk Factor Surveillance System results covering all of 2026. Researchers will be watching whether the substitution accelerates in newly legal states like Ohio and Florida, both of which launched adult-use sales in mid-2026.

For context on the broader consumer shift, see the CannIntel topic hub on cannabis as an alcohol substitute. The beverage industry's multi-billion-dollar bet suggests they're taking the trend seriously—whether public-health policy will follow remains an open question.